BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16882345)

  • 1. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
    Zhu WY; Hunag YY; Liu XG; He JY; Chen DD; Zeng F; Zhou JH; Zhang YK
    Anat Rec (Hoboken); 2012 Feb; 295(2):208-14. PubMed ID: 22190510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
    Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H
    Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
    Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
    Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
    Werynska B; Pula B; Muszczynska-Bernhard B; Piotrowska A; Jethon A; Podhorska-Okolow M; Dziegiel P; Jankowska R
    Anticancer Res; 2011 Sep; 31(9):2833-9. PubMed ID: 21868526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.
    Yang J; Tan D; Asch HL; Swede H; Bepler G; Geradts J; Moysich KB
    Lung Cancer; 2004 Oct; 46(1):29-42. PubMed ID: 15364130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
    Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
    Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
    Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
    Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
    May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
    BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
    Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
    Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Takeda K; Aburatani H; Oizumi S; Konishi J; Kaga K; Matsuno Y; Birrer MJ; Nishimura M; Dosaka-Akita H
    Lung Cancer; 2011 May; 72(2):229-37. PubMed ID: 20884074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
    Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
    J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade.
    Burger M; Denzinger S; Hartmann A; Wieland WF; Stoehr R; Obermann EC
    Br J Cancer; 2007 Jun; 96(11):1711-5. PubMed ID: 17505513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.